The humanoid robotics race is splitting into two lanes: Chinese manufacturers putting real robots into real hands, and a Western incumbent whose valuation thesis rests on units that have not yet reached customers.
Why it matters
The gap between shipping product and projecting value defines the current moment in humanoid robotics. Ubtech Robotics began delivering its UWorld U1 companion humanoid to private buyers in China on September 162. Unitree turned profitable in 2025 on RMB 1.70 billion in revenue, with humanoid robots becoming its largest business line3. Meanwhile, Elon Musk's claim that Optimus represents "literally a $25 trillion market cap situation" remains tethered to a robot that Tesla has not yet sold commercially1. ANALYSIS The contrast frames a broader question for investors: whether the robotics market will reward early shippers or the platform player that arrives later with deeper integration.
The big picture
JPMorgan Chase estimates that robotics-industry sales were $100 billion in 2025 and could reach $2.5 trillion by 2035. That forecast is the gravitational center around which every valuation argument orbits. If Tesla captured 10 percent of that projected global market by 2035, its robotics division could be valued at roughly $3 trillion, according to one analysis, a figure far short of Musk's $25 trillion aspiration. For context, the entire S&P 500 is worth roughly $70 trillion.
The Chinese players are not waiting for the market to mature. Ubtech's U1 spans price tags from 119,800 yuan to 990,000 yuan (roughly $16,500 to $135,000 depending on configuration), and more than 13,000 reservation deposits have reportedly been placed, though the company has not confirmed those figures through regulatory filings. Ubtech also commissioned its Super Smart Factory in Liuzhou, a 14,000-square-meter facility targeting annual capacity exceeding 10,000 units and running at a pace of one robot every ten minutes. The factory is geared toward the Walker S and Cruzr lines.
Unitree, preparing for its IPO, produced 26,032 quadruped robots and 5,716 humanoid robots in 2025. The company plans to invest approximately RMB 4.20 billion of IPO proceeds across four projects, with around RMB 2.02 billion allocated to intelligent robot model research and development and approximately RMB 1.11 billion to robot body and core-technology development. Contract liabilities rose from RMB 29.1 million in 2023 to RMB 137.0 million in 2025, a trajectory that reflects growing prepaid orders.
ANALYSIS Ubtech's delivery milestone and factory commissioning represent a deliberate bet that the consumer humanoid category can be built from the ground up in China before Western competitors enter the market. Yet the stock market has not rewarded the effort: Ubtech shares were hovering just above their 52-week low of EUR 8.24 at Friday's close, down 40 percent since the start of the year. Since the Liuzhou plant came online, the stock has shed 6.2 percent.
That investor skepticism may reflect the wide price spread of the U1 and the unverified nature of the reservation figures. A companion robot priced up to $135,000 occupies an uncertain niche between industrial deployment and luxury consumer gadget.
Ubtech is simultaneously building international distribution. At Slovenia's MOS industrial trade fair on September 18, the company showcased its Walker C1 humanoid and signed a distribution agreement with Hiproject, granting exclusive sales rights across Slovenia, Croatia, Serbia, Bosnia and Herzegovina, and North Macedonia. Management also held talks with Kazakh President Kassym-Jomart Tokayev about a planned factory in Almaty that would be Ubtech's first production facility outside China, focused on educational and service robots.
Unitree's path looks different. The company employed 184 R&D personnel at the end of 2025, up from 104 in 2023. Inventory increased to RMB 367.8 million in 2025 from RMB 141.3 million in 2024. ANALYSIS Rising inventory alongside rising contract liabilities suggests Unitree is building ahead of confirmed demand, a classic pre-IPO scaling pattern that carries execution risk if orders slow.
Tesla currently trades at a 13 times price-to-sales ratio. ◆ Even a $3 trillion robotics valuation, the figure one analysis derives from a 10 percent share of JPMorgan's projected $2.5 trillion market, would fall far short of Musk's $25 trillion target, and the two Chinese competitors with actual shipping volume have a combined humanoid output measured in thousands of units, not the millions that such valuations would eventually require.
What's next
Unitree's IPO proceeds, totaling approximately RMB 4.20 billion across four projects, will fund a manufacturing base (roughly RMB 624.1 million) and new product development (RMB 445.4 million). Ubtech's planned Almaty factory, if finalized, would mark the first offshore production site for a Chinese humanoid maker. Tesla, for its part, "is spending billions to scale its robotics division", but has yet to announce a commercial delivery date. ◆ The companies shipping today are building the supply chains, distribution networks, and customer feedback loops that late entrants will need to match or leapfrog. The market's verdict on whether early volume or eventual scale matters more remains, for now, priced into Ubtech's 52-week low and Tesla's trillion-dollar premium.